Studies focusing on immune components within the tumor microenvironment could clarify FOLR1’s role in mediating interactions between cancer cells and immune compartments, providing valuable insights for selecting IMGN853 and immunotherapy combinations. The gene discussed is FOLR1; the disease is neoplasm.